Michal Voldiner Built an IV Room Into a Pharmacy Most Operators Would Skip

In California, a pharmacy cannot prepare a single sterile IV dose without a separate state license, and the state will not renew that license until an inspector has walked the room.

Michal Voldiner took that on while Ultimate Care Rx was still small.

The order of those two facts is the whole story. At the size a long-term care pharmacy eventually reaches, sterile compounding in house is what the category expects; a pharmacy serving a few thousand beds keeps that work under its own roof rather than farming it out. The operators who skip an IV room are the ones who haven’t gotten there yet, and who look at the capital and decide to wait one more year. Voldiner built hers before the bed count arrived to justify it.

The License Behind the Room

An IV room is not a capability a pharmacy can simply decide to have.

California requires a dedicated sterile compounding pharmacy license, and the rule is written as a prohibition: a pharmacy shall not compound sterile drug products for injection, administration into the eye, or inhalation unless it holds one. The licensing sits under Article 7.5 of the Business and Professions Code and a dedicated block of Title 16 regulations, and the condition attached to it is the part operators underestimate. The board will not issue or renew it until the location has been inspected and found in compliance with every regulation the board has adopted, which means the room is re-proved to a state inspector on a recurring cycle rather than cleared once at the start.

Federal expectations run the same way. IV capability sits inside the federal minimum performance criteria for pharmacies serving these communities, treated as a baseline alongside unit-dose packaging, 24/7 pharmacist access, and daily delivery, in Milliman’s analysis of the sector. That same analysis priced dispensing to a nursing home resident about 25% above retail, in a business with no retail aisle to spread the cost across.

Why Timing Is the Real Decision

Put those together and the interesting question stops being whether a long-term care pharmacy builds an IV room. It becomes when.

Build it early and the arithmetic works against you for a while. A cleanroom’s costs are mostly fixed and begin the day it opens: the room runs whether or not there’s enough work to fill it, staff need aseptic technique training and periodic recertification before the volume justifies the headcount, and capital sits in a space that earns nothing until the beds arrive.

Build it late and the constraint lands on residents instead. Every therapy involving an injectable or infused drug becomes one the pharmacy routes outside or declines, and communities learn which questions it can’t answer. Growth gets capped by what the pharmacy isn’t yet equipped to prepare.

The category is small enough that either choice is visible. Milliman counted 1,282 long-term care pharmacies operating in 2023 against a retail sector more than 61,700 locations deep, which puts the number of operators weighing an IV room in any given year in the hundreds rather than the thousands. There is no crowd to hide a decision like this in.

Michal Voldiner picked the first version early, at the point Ultimate Care Rx was outgrowing its original space. She was hiring through the same stretch, putting money into integrated software, and carrying inventory that insurance carriers had not yet reimbursed. Of everything on that list, the IV room was the line item easiest to justify postponing. She declined to postpone it.

What California Changed in October 2025

A pharmacy that holds the license also inherits every revision to the rules governing it.

Beginning Oct. 1, 2025, California sterile compounding pharmacies may compound with components from the FDA’s Bulks List, provided they comply with USP General Chapter 797 and applicable federal law and guidance. The same overhaul retired some long-standing California-only requirements, including the mandatory sterile preparation mats that compounding pharmacies handling hazardous drugs had been required to use.

Changes like those are why an IV room is an operating commitment rather than a construction project. Standards get revised, the state aligns its regulations to them, and a pharmacy holding a sterile compounding license absorbs each revision on the state’s schedule and demonstrates it at the next inspection. That ongoing obligation, more than the build cost, is what a smaller operator is really weighing.

Michal Voldiner’s Bet on Building Early

What the room bought Ultimate Care Rx was range.

A pharmacy with its own sterile suite can say yes to regimens another pharmacy has to hand off, and a clinical question about an infusion gets answered by the people who prepared it. Older residents move through dehydration, infection, and drug therapies a retail counter never touches. A community calling about one of those gets a plan rather than a referral.

None of that showed up on a spreadsheet in the year the room was built. According to the company, it showed up later, in the communities across Los Angeles County that stayed with the pharmacy and in residents it did not have to send elsewhere. Voldiner treated the IV room as infrastructure the pharmacy would grow into rather than a reward for having already grown. That is the version of the decision most operators at that stage talk themselves out of, and the reason the room was finished before anyone could point to the volume that would have made it obvious.

For a broader look at compounding in patient care, see this MedicalResearch.com overview of custom compounding for personalized healthcare.

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links are sponsored. MedicalResearch.com and Eminent Domains Inc. do not warrant or endorse products or claims made by third party links. Always seek the advice of your physician or other qualified health provider and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.